FDA Inspection 1009015 — Loma Linda University Medical Center

Loma Linda University Medical Center — FEI 2017366

The FDA completed an inspection of Loma Linda University Medical Center on March 30, 2017 in Loma Linda, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 30, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Loma Linda, CA (United States)